Charles River Laboratories International, Inc. (CRL) — Stock Score Summary

Charles River Laboratories International, Inc. (CRL) has a MoatMap StockRank of 66/100 based on Quality (45/100), Value (41/100), and Momentum (64/100) factor scores. The current signal is BUY. Charles River Laboratories is a critical gatekeeper in early-stage drug discovery. While it stands to benefit from a recovery in biotech funding and CDMO outsourcing, near-term headwinds in global pharma R&D spending warrant a cautious, monitoring stance.

Charles River Laboratories International, Inc. is a leading global contract research organization (CRO), providing a comprehensive suite of preclinical and clinical laboratory services to pharmaceutical, biotechnology, government, and academic clients. The company's competitive moat stems from its integrated service offerings, specialized scientific expertise, global operational scale, and the high switching costs for its clients in critical drug development phases. It serves as an indispensable partner in early-stage drug discovery and development.

Key Financial Metrics

Price$189.85
Market Cap$8.7B
P/E (Forward)15.09
Price/Book3.04
Return on Equity-5.9%
Return on Invested Capital0.1%
Debt/Equity102.55
Gross Margin34.5%
Operating Margin15.9%
Revenue Growth1.2%
Free Cash Flow$510M

Charles River Laboratories International, Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Charles River Laboratories International, Inc.’s (CRL) StockRank?
MoatMap’s StockRank for Charles River Laboratories International, Inc. (CRL) is 66/100, with a Buy signal. It is a composite of Quality (45), Value (41), and Momentum (64) factor ranks across MoatMap’s 19,000+ stock universe.
Does Charles River Laboratories International, Inc. have an economic moat?
Charles River Laboratories International, Inc. (CRL) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Charles River Laboratories International, Inc. a buy, hold, or sell?
MoatMap’s current signal for Charles River Laboratories International, Inc. (CRL) is Buy, based on a StockRank of 66/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. (CRL) operates in the Healthcare sector, specifically the Diagnostics & Research industry (United States).
Browse all ranked stocksCRL deep dive reportAI ChampionsHow we score stocksSense-check another stock